Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
New EMA Advice for PML Prevention With Fingolimod in MS
VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires.
Characterization of Multiple Sclerosis Plaques Using Susceptibility-Weighted Imaging at 1.5 T: Can Perivenular Localization Improve Specificity of Imaging Criteria?
Cutting Edge: AhR Is a Molecular Target of Calcitriol in Human T Cells.
Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating?
Impact of high intensity exercise on muscle morphology in EAE rats.
Multiple sclerosis increases the risk of infections resulting in a hospitalization among veterans.
[Demyelinating process in systematic rheumatoid diseases (review)].
Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity.
Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Multiparity in women with multiple sclerosis causes less long-term disability: Yes.
Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children.
CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis.
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations.
[Diagnosis and monitoring of multiple sclerosis : The value of optical coherence tomography.]
Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
Regulatory T cells in autoimmune neuroinflammation.
Intra-individual variability in information processing speed reflects white matter microstructure in multiple sclerosis.
Cognitive function alone is a poor predictor of health-related quality of life in employed patients with MS: results from a cross-sectional study.
Vaccination, infection, and the risk for multiple sclerosis.
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice.
[Progressive Multifocal Leukoencephalopathy with Inflammatory Reactions].
[Plasmapheresis in acute phase of multiple sclerosis].
Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.
Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remitting.
Pages
« first
‹ previous
…
555
556
557
558
559
560
561
562
563
…
next ›
last »